Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease
Ho Soo Chun, Minjong Lee, Hye Ah Lee, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 9, pp. 2298-2307.e18
Closed Access | Times Cited: 18

Showing 18 citing articles:

Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease
Stergios A. Pοlyzos, Ilias D. Vachliotis, Christos S. Mantzoros
Metabolism (2023) Vol. 147, pp. 155676-155676
Closed Access | Times Cited: 36
Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
Hong‐Kyu Kim, Sung‐Jin Bae, Min Jung Lee, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 987-1001
Open Access | Times Cited: 32
Identification of factors associated with sarcopenic obesity development: Literature review and expert panel voting
Alexandre Pinel, C. Guillet, Frédéric Capel, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 6, pp. 1414-1424
Open Access | Times Cited: 13
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease
Alessandra Musio, Federica Perazza, Laura Leoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7517-7517
Open Access | Times Cited: 15
The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
Xiaoyan Li, Jie He, Qiuhua Sun
Clinical Nutrition (2024) Vol. 43, Iss. 9, pp. 2005-2016
Open Access | Times Cited: 5
Metabolic-Associated Fatty Liver Disease and Sarcopenia
Triada Bali, Lampros Chrysavgis, Εvangelos Cholongitas
Endocrinology and Metabolism Clinics of North America (2023) Vol. 52, Iss. 3, pp. 497-508
Closed Access | Times Cited: 10
Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease
Suprabhat Giri, Prajna Anirvan, Sumaswi Angadi, et al.
World Journal of Gastrointestinal Pathophysiology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Sarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships
В. А. Ахмедов, V. S. Marinenko
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 110-118
Closed Access
Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment
Yuping Ding, Quanjun Deng, Mei Yang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 3303-3329
Open Access | Times Cited: 8
The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review
Frederick Berro Rivera, Arcel V. Adizas, Deanna Cubarrubias, et al.
Journal of the ASEAN Federation of Endocrine Societies (2024) Vol. 39, Iss. 1, pp. 84-94
Open Access | Times Cited: 2
The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients
Alexander S. Vogel, Rebecca Roediger, Dagny Von Ahrens, et al.
Life (2024) Vol. 14, Iss. 6, pp. 685-685
Open Access | Times Cited: 1
Association of muscle mass, grip strength and fat-to-muscle ratio and metabolic dysfunction-associated steatotic liver disease in a middle-to-elderly aged population
Si‐Yang Maggie Liu, Yajun He, Genfeng Yu, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
A Comprehensive Review of Essential Aspects of Molecular Pathophysiological Mechanisms with Emerging Interventions for Sarcopenia in Older People
Priyanka Prajapati, Anand Kumar, Rishabh Chaudary, et al.
Current Molecular Pharmacology (2023) Vol. 17
Open Access | Times Cited: 2
Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease
Rongtao Lai, Mindie H. Nguyen
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 11, pp. 2984-2984
Open Access | Times Cited: 1
Sarcopenic obesity in patients awaiting liver transplant: Unique challenges for nutritional recommendations
Darya M. Herscovici, Katherine M Cooper, Alessandro Colletta, et al.
World Journal of Transplantation (2024) Vol. 14, Iss. 2
Open Access
Exploring the Clinical and Pathophysiological Links between Sarcopenia and Liver Pathology
В. А. Сергеева, Н. К. Рунихина, N. Yu. Shulpina
Russian Journal of Geriatric Medicine (2024), Iss. 3, pp. 216-224
Closed Access
Cardiovascular and Liver Diseases in Subjects With Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease
Tomoyuki Kawada
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 10, pp. 2704-2705
Open Access
Hepatocyte steatosis activates macrophage inflammatory response accelerating atherosclerosis development
Yue Li, X.-c. Wu, Jiaxiang PAN, et al.
Journal of Zhejiang University (Medical Sciences) (2023) Vol. 52, Iss. 6, pp. 751-765
Open Access
Page 1

Scroll to top